Finance

Lists
T1CH34:BVMF
Bio Techne Corporation Bdr
R$12,14
0,00%
(0,00) 1D
5 Okt., 10:02:32 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for T1CH34...
Mkt. cap
11,37 mjd
Avg. vol.
47,00
Volume
0,00
52-wk high
R$12,66
52-wk low
R$7,33
Shares outstanding
156,82 m
No. of employees
3 k
Mkt. cap
11,37 mjd
Avg. vol.
47,00
Volume
0,00
52-wk high
R$12,66
52-wk low
R$7,33
Shares outstanding
156,82 m
No. of employees
3 k
News stories
From web sources and news partners
Profile
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets. Wikipedia
About Bio Techne Corporation Bdr
CEOKim Kelderman
Employees3 k
Founded1976
HeadquartersMinneapolis, Minnesota, Verenigde State van Amerika
SectorHealth care
Websitebio-techne.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
286,56 m
295,88 m
311,42 m
321,19 m
Cost of goods sold
96,36 m
102,69 m
101,98 m
109,14 m
Cost of revenue
96,36 m
102,69 m
101,98 m
109,14 m
Research and development expenses
24,24 m
23,12 m
23,46 m
23,94 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
117,57 m
111,87 m
107,54 m
98,59 m
Operating expense
141,81 m
134,99 m
130,99 m
122,53 m
Total operating expenses
238,18 m
237,68 m
232,97 m
231,67 m
Operating income
48,38 m
58,20 m
78,45 m
89,52 m
Other non operating income
2,00 m
-2,51 m
-2,11 m
1,89 m
EBT including unusual items
47,99 m
50,78 m
71,22 m
70,68 m
EBT excluding unusual items
48,71 m
54,52 m
74,18 m
91,79 m
Income tax expense
9,81 m
12,78 m
20,18 m
16,06 m
Effective tax rate
20,43%
25,16%
28,33%
22,72%
Other operating expenses
-
-
-
-
Net income
38,18 m
38,01 m
51,05 m
54,62 m
Net profit margin
13,33%
12,85%
16,39%
17,01%
Earnings per share
0,42
0,46
0,53
0,52
Interest and investment income
971,00 k
897,00 k
981,00 k
1,37 m
Interest expense
-2,93 m
-2,17 m
-2,40 m
-2,12 m
Net interest expenses
-1,96 m
-1,27 m
-1,42 m
-750,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
72,72 m
82,91 m
102,62 m
113,66 m
Gain or loss from assets sale
-6,79 m
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme